Amyloid-β and tau disrupt brain activity, driving early cognitive decline in Alzheimer’s risk

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive decline in older adults at risk of Alzheimer’s disease.

Aware Health Secures $3M for Value-Based Musculoskeletal Solution

What You Should Know: – Aware Health, a leading innovator in value-based musculoskeletal (“MSK”) solutions, today announced the successful close of a $3 million seed funding

October 9, 2024

Does eating carbohydrates impact facial attractiveness?

Researchers investigate the potential of medical disorders like hyperinsulinemia and hyperglycemia to influence facial attractiveness.

March 12, 2024

Patient-derived organoids: Transforming cancer research and personalized medicine

Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment through advanced 3D modeling techniques.

November 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.